Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.01 per share
-
Shares outstanding
-
46,239,275
-
Total 13F shares
-
1,552,651
-
Share change
-
+266,825
-
Total reported value
-
$36,360,574
-
Price per share
-
$23.42
-
Number of holders
-
9
-
Value change
-
+$6,421,788
-
Number of buys
-
3
-
Number of sells
-
3
Institutional Holders of UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) as of Q4 2025
As of 31 Dec 2025,
UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,552,651 shares.
The largest 9 holders included
SG Americas Securities, LLC, Hennion & Walsh Asset Management, Inc., SHIKIAR ASSET MANAGEMENT INC, Newbridge Financial Services Group, Inc., Sound Income Strategies, LLC, NISA INVESTMENT ADVISORS, LLC, GAMMA Investing LLC, True Wealth Design, LLC, and SIGNATUREFD, LLC.
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.